New #MolTherapy paper: Delpacibart Etedesiran Improves the Molecular Pathology of Myotonic Dystrophy Type 1 in the Phase 1/2 MARINA® Study. #Myoblue tinyurl.com/3kbu3ty3
New #MolTherapy paper: AUF1 therapy blocks atrophy, promotes regeneration, re-innervation and strength for severe muscle injury. #Myoblue tinyurl.com/3bmnxr8d
#LipidNanoParticle functionalized with Myomerger extracellular domain for #SkeletalMuscle targeting (+ liver detargeting by 85% at 24 h i.m 😎) delivery of nucleic acids
⏬ innate immune response in lymph node & muscle by 24 h i.m.
#MyoSky
#MolTherapy 2026
www.cell.com/molecular-th...
Induced EndMT status enhances AAV6 or AVV9 transduction efficiency in Cardiac Endothelial Cell by 5~10 fold in vitro & ~3 fold in vivo
Vatalanib
siVEGFR1
siVEGFR2
siPECAM1
TGFβ2
Experimental myocardial infarction
#MolTherapy 2024
www.cell.com/molecular-th...
p21-ATD🐭for p21+ senescent cell tracking & elimination in #Aging & Liver injury
#HereditaryTyrosinemia Fah1 KO🐭
Senescent hepatocytes are mainly p21+ p16-
p21 cell ablation
⏬tyrosinemic liver-derived CCL2 & ⏫donor hepatocyte engraftment
#MolTherapy 2024
www.sciencedirect.com/science/arti...
New #MolTherapy paper: Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy. #DMD #Myoblue tinyurl.com/4f5tj2xn
New #MolTherapy paper: Development of an AAV-delivered microRNA gene therapy for Myotonic Dystrophy Type 1. #Myoblue tinyurl.com/mrjrue3f
New #MolTherapy paper: AAV-microutrophin gene therapy confers long-term cardioprotection against pharmacologic and exercise-induced injury in dystrophin deficiency. #Myoblue tinyurl.com/ypdkckmc
Congrats to #ronald_cohn & colleagues for their new #MolTherapy paper: Template-assisted sequence knock-in rescues skeletal and cardiac muscle function in a deletion model of Duchenne muscular dystrophy. tinyurl.com/5x2sk6j2
Systematic screening of 2042👤miRNAs➡️
7 new miRs (miR-323a-3p, -449b-5p, -491-3p, -892b, -1827, -4774-3p, -5681b) that⏬#SmoothMuscleCell (of multi-vascular beds) proliferation w/o cytotoxicity
miR-323a-3p & -449b-5p validated on ex vivo👤vein graft
#MolTherapy 2024
www.cell.com/molecular-th...